Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

New ZAP70 and Syk kinase inhibitors claimed by NeoGenesis

Nov. 4, 2004

New beta-secretase inhibitors under evaluation at GSK

Nov. 4, 2004

Ono researchers develop novel chemokine CCR5 antagonists

Nov. 4, 2004

Millennium presents new ALK5 inhibitors and their potential applications

Nov. 4, 2004

Novel 5-HT6 receptor ligands designed by GSK scientists

Nov. 4, 2004

Two series of MCH receptor antagonists developed at Neurocrine

Nov. 4, 2004

New factor XIa inhibitors identified by BMS researchers

Nov. 3, 2004

New Chk1 kinase inhibitors under study at Abbott

Nov. 3, 2004

New phenylsulfonamide-based gamma-secretase inhibitors and their use in AD

Nov. 3, 2004

New factor Xa inhibitors in early development at Boehringer Ingelheim

Nov. 3, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...